🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Tafenoquine was recently approved by regulatory authorities in the USA and ...
Status
Recruiting
Location
Mahidol Oxford Tropical Medicine Research Unit (MORU), Cambodia
Start Date
2024-07-22
Trial ID
NCT04704999
Theoretically, so long as there is a sink-source for malaria, transmission ...
Status
Completed
Location
Shoklo Malaria Research Unit (SMRU)
Start Date
2025-02-19
Trial ID
NCT06575647
Treatments Being Tested
The investigators are proposing a new malaria control strategy to reach the...
Status
Completed
Location
Josiane Muller
Start Date
2022-09-12
Trial ID
NCT05540470
Treatments Being Tested
This is a prospective, double-blind, double-dummy, multicenter, comparative...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-04-30
Trial ID
NCT02216123
Treatments Being Tested
Tafenoquine (TQ) is an 8-aminoquinoline anti-malarial drug which is in deve...
Status
Completed
Location
GSK Investigational Site
Start Date
2018-04-08
Trial ID
NCT02802501
In this area of Greater Mekong Subregion (GMS), vivax malaria is the most c...
Status
Recruiting
Location
Shoklo Malaria Research Unit (SMRU)
Start Date
2023-06-26
Trial ID
NCT05788094
This is a prospective, open-label, multicenter, non-comparative, single arm...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-02-06
Trial ID
NCT02563496
Treatments Being Tested
The study aims to provide evidence of retinal safety to support the use of ...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-02-02
Trial ID
NCT02658435
Treatments Being Tested
This study is to conduct a clinical trial of tafenoquine combinations to co...
Status
Not Yet Recruiting
Location
Tha Song Yang Hospital
Start Date
2026-05-01
Trial ID
NCT07533136
This study will investigate the effect of Tafenoquine (TQ) 150 mg tablet ag...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-05
Trial ID
NCT02751294
Treatments Being Tested